University of Maryland, Baltimore 660 West Redwood Street Baltimore, MD 21202 (410) 706-8282 Jane M. Shaab, Vice President, Business Development

The UMB BioPark is a new biomedical research park on the campus of the University of Maryland, Baltimore, a top-10 public research institution. The BioPark is being built on ten acres of land on the 800 and 900 blocks of West Baltimore Street.  It offers flexible wet lab and office space for private corporations and university researchers to collaborate in the commercialization of bioscience innovations.  Once completed, the project will include:

• Ten buildings containing 1.2 million square-feet of lab and office space
• Parking garages
• Landscaped parks

Building One, a six-story 120,000 square foot building, opened in 2005 and is fully leased.  Building Two is six stories, 215,000 square feet and was completed in 2007 with space still available.  The multi-tenant building includes conference facilities, space suitable for GMP manufacturing and a BioAccelerator for early-stage bioscience companies.  Building Three is proposed for six stories and 180,000 square feet with delivery in 2009.  Eight greenfield sites, ranging from 80,000 to 100,000 square feet, are also available.  Of them, four sites are pre-zoned for biomedical research buildings.

Founded in 1807, the University of Maryland, Baltimore is a leader in graduate and professional education in dentistry, law, medicine, nursing, pharmacy and social work. With $380 million in sponsored research in FY 2005, UMB is ranked 8th among public institutions for NIH research funding.  Together with its major partners located on the downtown campus—the University of Maryland Medical Center, the Institute for Human Virology, Shock Trauma Center, the Veterans Administration Hospital and the UMB BioPark—the University provides an ideal environment for training, research, clinical trials and biomedical commercialization.  Areas of research excellence include:

• Biodefense
• Cancer
• Drug development
• HIV / AIDS
• Infectious diseases
• Neuroscience
• Vaccine development
• Vascular biology